{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:34:14Z","timestamp":1793223254666,"version":"4.5.0"},"reference-count":13,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3,1]]},"abstract":"<jats:p>OBJECTIVES. Establishing pediatric reference intervals has always been challenging, with most ranges used in pediatric laboratories developed over many years. The clinical interpretation of gonadotropins is important in the context of ambiguous genitalia. The aim of this study was to develop reference intervals for luteinizing hormone and follicle-stimulating hormone in infants born between 24 and 29 weeks\u2019 gestation.<\/jats:p>\n               <jats:p>METHODS. Samples were collected at 0 to 43 days after birth from 82 premature infants born &amp;lt;30 weeks\u2019 gestation for analysis of luteinizing hormone and follicle-stimulating hormone by automated immunochemiluminometric immunoassays.<\/jats:p>\n               <jats:p>RESULTS. The 43 male infants demonstrated a range of luteinizing hormone levels from 0.1 to 13.4 IU\/L and of follicle-stimulating hormone levels from 0.3 to 4.6 IU\/L. The 39 female infants demonstrated a range of luteinizing hormone levels from 0.2 to 54.4 IU\/L and of follicle-stimulating hormone levels from 1.2 to 167.0 IU\/L. The ratio of luteinizing hormone\/follicle-stimulating hormone levels differed with males, ranging from 0.3 to 9.4, and females, at &amp;lt;0.5.<\/jats:p>\n               <jats:p>CONCLUSION. These data provide guidance for the interpretation of luteinizing hormone and follicle-stimulating hormone levels for the first 6 weeks of life in extremely premature infants born between 24 and 29 weeks\u2019 gestation. The availability of age-appropriate reference intervals is essential for correct and timely interpretation of biochemical results to the clinician.<\/jats:p>","DOI":"10.1542\/peds.2007-1327","type":"journal-article","created":{"date-parts":[[2008,2,29]],"date-time":"2008-02-29T14:48:09Z","timestamp":1204296489000},"page":"e574-e580","source":"Crossref","is-referenced-by-count":34,"title":["Luteinizing Hormone and Follicle-Stimulating Hormone Levels in Extreme Prematurity: Development of Reference Intervals"],"prefix":"10.1542","volume":"121","author":[{"given":"Ronda F.","family":"Greaves","sequence":"first","affiliation":[{"name":"Departments of Complex Biochemistry"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney W.","family":"Hunt","sequence":"additional","affiliation":[{"name":"Neonatal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela S.","family":"Chiriano","sequence":"additional","affiliation":[{"name":"Core Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret R.","family":"Zacharin","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes, Royal Children's Hospital, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2008,3,1]]},"reference":[{"key":"2021120905495323300_R1","doi-asserted-by":"crossref","unstructured":"Verras P, Greaves R. Abnormal laboratory results: important issues to consider in the interpretation of paediatric biochemistry. Aust Prescriber.2005;28(5):126\u2013129","DOI":"10.18773\/austprescr.2005.096"},{"key":"2021120905495323300_R2","unstructured":"National Health and Medical Research Council. Care Around Preterm Birth. Clinical Practice Guidelines. Canberra, Australia: Australian Government Publishing Service;1997"},{"key":"2021120905495323300_R3","doi-asserted-by":"crossref","unstructured":"Greaves R, Kanumakala S, Read A, Zacharin M. Transient 3 beta HSD deficiency and ambiguous genitalia in premature babies. J Paediatr Child Health.2004;40(4):233\u2013236","DOI":"10.1111\/j.1440-1754.2004.00345.x"},{"key":"2021120905495323300_R4","doi-asserted-by":"crossref","unstructured":"Kaplan S, Grumbach M. The ontogenesis of human foetal hormones. II. Luteinizing hormone (LH) and follicle stimulating hormone (FSH). Acta Endocrinol.1976;81(4):808\u2013829","DOI":"10.1530\/acta.0.0810808"},{"key":"2021120905495323300_R5","doi-asserted-by":"crossref","unstructured":"Shinkawa O, Furuhashi N, Fukaya T, Suzuki M, Kono H, Tachibana Y. Changes of serum gonadotropins levels and sex difference in premature and mature infants during neonatal life. J Clin Endocrinol Metab.1983;56(6):1327\u20131331","DOI":"10.1210\/jcem-56-6-1327"},{"key":"2021120905495323300_R6","doi-asserted-by":"crossref","unstructured":"Massa G, de Zegher F, Vanderschueren-Lodeweyckx. Serum levels of immunoreactive inhibin, FSH, and LH in human infants at preterm and term birth. Biol Neonate.1992;61(3):150\u2013155","DOI":"10.1159\/000243737"},{"key":"2021120905495323300_R7","doi-asserted-by":"crossref","unstructured":"Trotter A, Maier L, Grill H-J, Kohn T, Heckmann M, Pohlandt F. Effects of postnatal estradiol and progesterone replacement in extremely preterm infants. J Clin Endocrinol Metab.1999;84(12):4531\u20134535","DOI":"10.1210\/jcem.84.12.6180"},{"key":"2021120905495323300_R8","unstructured":"Solberg HE. Establishment and Use of Reference Values in Tietz Textbook of Clinical Chemistry. 2nd ed. Philadelphia, PA: WB Saunders Company;1994:454\u2013484"},{"key":"2021120905495323300_R9","doi-asserted-by":"crossref","unstructured":"Schmidt H, Schwarz HP. Serum concentrations of LH and FSH in the healthy newborn. Eur J Endocrinol.2000;143(2):213\u2013215","DOI":"10.1530\/eje.0.1430213"},{"key":"2021120905495323300_R10","doi-asserted-by":"crossref","unstructured":"Midgley PC, Russell K, Oates N, Shaw JCL, Honour JW. Activity of the adrenal fetal zone in preterm infants continues to term. Endocr Res.1996;22(4):729\u2013733","DOI":"10.1080\/07435809609043769"},{"key":"2021120905495323300_R11","doi-asserted-by":"crossref","unstructured":"Corbier P, Dehennin L, Castanier M, Mebazaa A, Edwards D, Roffi J. Sex differences in serum luteinizing hormone and testosterone in the human neonate during the first few hours after birth. J Clin Endocrinol Metab.1990;71(5):1344\u20131348","DOI":"10.1210\/jcem-71-5-1344"},{"key":"2021120905495323300_R12","doi-asserted-by":"crossref","unstructured":"Mercado M, Yu VY, Fancis I, Szymonowicz W, Gold H. Thyroid function in very preterm infants. Early Hum Dev.1988;16(2\u20133):131\u2013141","DOI":"10.1016\/0378-3782(88)90093-X"},{"key":"2021120905495323300_R13","doi-asserted-by":"crossref","unstructured":"Sikaris K. McLachlan R, Kazlauskas R, de Kretser D, Holden C, Handelsman D. Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays. J Clin Endocrinol Metab.2005;90(11):5928\u20135936","DOI":"10.1210\/jc.2005-0962"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/3\/e574\/1123880\/zpe0030800e574.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/3\/e574\/1123880\/zpe0030800e574.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T23:41:27Z","timestamp":1639093287000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/121\/3\/e574\/72847\/Luteinizing-Hormone-and-Follicle-Stimulating"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,1]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,3,1]]},"published-print":{"date-parts":[[2008,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-1327","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,1]]}}}